摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5(6)-Ethoxycarbonyl-benzofuroxan | 39060-33-8

中文名称
——
中文别名
——
英文名称
5(6)-Ethoxycarbonyl-benzofuroxan
英文别名
3-oxy-benzo[1,2,5]oxadiazole-5-carboxylic acid ethyl ester;Ethyl 3-oxido-2,1,3-benzoxadiazol-3-ium-5-carboxylate
5(6)-Ethoxycarbonyl-benzofuroxan化学式
CAS
39060-33-8
化学式
C9H8N2O4
mdl
——
分子量
208.174
InChiKey
LWNNTOUMKJKTKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    77.8
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    5(6)-Ethoxycarbonyl-benzofuroxanN-乙酰乙酰苯胺C.I.酸性橙108 、 calcium chloride 作用下, 以 甲醇 为溶剂, 以22.4%的产率得到ethyl 2-phenylamide-3-methylquinoxaline-7-carboxylate 1,4-di-N-oxide
    参考文献:
    名称:
    Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica
    摘要:
    In our search for new antiamoebic agents, a new series of ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives have been synthesized using the Beirut reaction. All compounds were characterized by spectroscopic techniques and elemental analysis. Antiamoebic activity was evaluated in vitro against Entamoeba histolytica strain HM1:IMSS by the microdilution method, and the structure-activity relationship was analyzed. We found that eleven quinoxaline derivatives showed greater activity than metronidazole and nitazoxanide with IC50 values in the range 1.99-0.35 mu M. Compounds T-001 and T-016 shows IC50 values of 1.41 and 1.47 mu M, respectively, with a value of selectivity index >60. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.05.036
点击查看最新优质反应信息

文献信息

  • <i>In vitro</i> and <i>In Vivo</i> Evaluation of Quinoxaline 1,4-di-N-oxide Against <i>Giardia lamblia</i>
    作者:Elizabeth Barbosa-Cabrera、Rosa Moo-Puc、Antonio Monge、Alma Delia Paz-González、Virgilio Bocanegra-García、Gildardo Rivera
    DOI:10.2174/1570180816666190618115854
    日期:2020.4.25
    Background:

    Giardiasis is an important public health problem. However, its pharmacological treatment is limited mainly to two drugs, metronidazole and nitazoxanide. Objectives: Screening four series of esters (methyl, ethyl, isopropyl and n-propyl) of quinoxaline-7- carboxylate 1,4-di-N-oxide in in vitro and in vivo models as antigiardiasis agents.

    Objectives:

    Screening four series of esters (methyl, ethyl, isopropyl and n-propyl) of quinoxaline-7- carboxylate 1,4-di-N-oxide in in vitro and in vivo models as antigiardiasis agents.

    Methods:

    Briefly, 4 × 104 trophozoites of G. lamblia were incubated for 48 h at 37 °C with different concentrations of esters of quinoxaline-7-carboxylate 1,4-di-N-oxide, albendazole, metronidazole and nitazoxanide. Afterwards, trophozoites were counted and the half maximal inhibitory concentration (IC50) was calculated by Probit analysis. The in vivo antigiardial activity of the compounds was demonstrated using experimental infections of G. lamblia in suckling female CD-1 mice.

    Results:

    Compound T-069 with a thienyl, a trifluoromethyl and an isopropyl group at R1-, R2- and R3-position, respectively, on the quinoxaline 1,4-di-N-oxide ring in an in vitro model showed an IC50 value of 0.0014 µM, and 3502 and 1108 times more giardicidal activity than nitazoxanide and metronidazole in an in vivo model.

    Conclusion:

    Isopropyl ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives showed better giardicidal activity than the reference drugs; therefore, these compounds are good candidates to develop new pharmacological treatment for giardiasis.

    背景:贾第虫病是一个重要的公共卫生问题。然而,其药物治疗主要局限于两种药物,甲硝唑和硝唑酮。目标:在体外和体内模型中筛选四系列喹诺酮-7-羧酸二-N-氧化物(甲基、乙基、异丙基和正丙基)的酯类化合物作为抗贾第虫药剂。 目标:在体外和体内模型中筛选四系列喹诺酮-7-羧酸二-N-氧化物(甲基、乙基、异丙基和正丙基)的酯类化合物作为抗贾第虫药剂。 方法:简而言之,将4 × 104个贾第虫滋养体与不同浓度的喹诺酮-7-羧酸二-N-氧化物酯类、阿苯达唑、甲硝唑和硝唑酮一起在37°C下孵育48小时。然后,对滋养体进行计数,并通过Probit分析计算半最大抑制浓度(IC50)。这些化合物的体内抗贾第虫活性是通过在哺乳期雌性CD-1小鼠中进行贾第虫实验性感染来证明的。 结果:在体外模型中,具有噻吩基、三氟甲基和异丙基基团分别位于喹诺酮-7-羧酸二-N-氧化物环的R1、R2和R3位置的化合物T-069显示出IC50值为0.0014微米,在体内模型中的贾第杀灭活性比硝唑酮和甲硝唑分别高出3502倍和1108倍。 结论:喹诺酮-7-羧酸二-N-氧化物的异丙基酯衍生物显示出比参考药物更好的贾第杀灭活性;因此,这些化合物是开发新的贾第虫病药物治疗的良好候选。
  • Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica
    作者:Blanca Estela Duque-Montaño、Lilia Citlalli Gómez-Caro、Mario Sanchez-Sanchez、Antonio Monge、Efrén Hernández-Baltazar、Gildardo Rivera、Oscar Torres-Angeles
    DOI:10.1016/j.bmc.2013.05.036
    日期:2013.8
    In our search for new antiamoebic agents, a new series of ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives have been synthesized using the Beirut reaction. All compounds were characterized by spectroscopic techniques and elemental analysis. Antiamoebic activity was evaluated in vitro against Entamoeba histolytica strain HM1:IMSS by the microdilution method, and the structure-activity relationship was analyzed. We found that eleven quinoxaline derivatives showed greater activity than metronidazole and nitazoxanide with IC50 values in the range 1.99-0.35 mu M. Compounds T-001 and T-016 shows IC50 values of 1.41 and 1.47 mu M, respectively, with a value of selectivity index >60. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

重氮二硝基苯酚 达罗地平 苯并芙咱-5-硼酸频那醇酯 苯并氧化呋咱-5-羧酸 苯并呋扎-5-甲腈 苯并呋喃-5-磺酰氯 苯并呋喃-5-甲酸乙酯 苯并呋喃 苯并呋咱-5-羧酸乙酯 苯并呋咱-5-羧酸 苯并呋咱-5-碳酰氯 苯并呋咱 苯并二唑-4-甲醛 苯呋咱-5-三氟硼酸钾 硝基氨基吡咯烷苯并恶嗪 哌嗪酮,6-甲基-5-硫代-,(R)-(9CI) 去甲基伊拉地平 伊拉地平内酯 伊拉地平EP杂质A 伊拉地平 乙酮,1-[5-(丁基氨基)-2-羟基苯基]- NBD-双十六胺 N-[12-[((7-硝基-2-1,3-苯并恶二唑-4-基)氨基]十二烷酰基]-D-赤型-鞘氨醇 N-7-(4-硝基苯并-2-氧代-1,3-二氮唑)-omega-氨基己酸beta-(N-三甲基铵)乙酯 N-(7-硝基苯并-2-氧杂-1,3-二氮唑-4-基)磷脂酰乙醇胺 N-(3-氯-5-氟苯基)-4-硝基-2,1,3-苯并恶二唑-5-胺 N-(2-吗啉基乙基)-7-硝基-2,1,3-苯并恶二唑-4-胺 N,N-二甲基-7-硝基苯并呋咱-4-胺 N,N-二丁基-7-硝基-4-苯并呋咱胺 N'-[5-[[4-[5-(乙酰基-羟基氨基)戊基氨基]-4-氧代丁酰基]-羟基氨基]戊基]-N-羟基-N-[5-[(4-硝基-2,1,3-苯并恶二唑-7-基)氨基]戊基]丁二酰胺 8-异米索前列醇 7-肼-N,N-二-4-苯并呋咱磺 7-硝基-N-[2-(2-吡啶基二硫代)乙基]-2,1,3-苯并恶二唑-4-胺 7-硝基-1-氧代-2,1,3-苯并恶二唑-1-鎓 7-甲氧基-2,1,3-苯并恶二唑-4-磺酰氯 7-氯苯并[c][1,2,5]噁二唑-4-胺 7-氯-N,N-二乙基-4-硝基-2,1,3-苯并恶二唑-5-胺 7-氯-4-硝基-5-哌啶基-2,1,3-苯并噁二唑 7-氯-4-硝基-2,1,3-苯并噁二唑1-氧化 7-氯-2,1,3-苯并噁二唑-4-磺酸 7-氟苯呋咱-4-磺酰胺 7-氟苯呋咱-4-硫氨 7-氟-2,1,3-苯并恶二唑-4-磺酰氯 7-哌啶-1-基-2,1,3-苯并恶二唑-4-胺 7-吗啉-4-基苯并[1,2,5]恶二唑-4-基胺 6-溴苯并[c][1,2,5]噁二唑1-氧化物 6-氟-2,1,3-苯并恶二唑-5-胺 6-[[7-(N,N-二甲氨基磺酰)-2,1,3-苯并恶二唑-4-基]氨基]己酸琥珀酰亚胺酯 6-[(7-硝基-2,1,3-苯并恶二唑-4-基)氨基]己酸 6,7-二氢-1,2,3,10-四甲氧基-7-[甲基(7-硝基-2,1,3-苯并恶二唑-4-基)氨基]-(7S)-苯并[a]庚搭烯-9(5H)-酮